I agree that this site is using cookies. You can find further informations here.
X
Szlosarek, Peter W.
70  results:
Search for persons X
?
1

Correction: A role for macrophages under cytokine control i..:

Phillips, Melissa M. ; Pavlyk, Iuliia ; Allen, Michael...
Pharmacological Reports.  , 2023
Link: https://doi.org/10.1007/..
 
?
2

A role for macrophages under cytokine control in mediating ..:

Phillips, Melissa M. ; Pavlyk, Iuliia ; Allen, Michael...
Pharmacological Reports.  75 (2023)  3 - p. 570-584 , 2023
Link: https://doi.org/10.1007/..
 
?
3

BAP1 Loss Is Associated with Higher ASS1 Expression in Epit..:

Barnett, Sarah E. ; Kenyani, Jenna ; Tripari, Martina...
Molecular Cancer Research.  21 (2023)  5 - p. 411-427 , 2023
Link: https://doi.org/10.1158/..
 
?
4

Bench-to-Bedside Studies of Arginine Deprivation in Cancer:

Field, George C. ; Pavlyk, Iuliia ; Szlosarek, Peter W.
Molecules.  28 (2023)  5 - p. 2150 , 2023
Link: https://doi.org/10.3390/..
 
?
5

Arginine Deprivation in SCLC: Mechanisms and Perspectives f..:

Carpentier, Joséphine ; Pavlyk, Iuliia ; Mukherjee, Uma..
Lung Cancer: Targets and Therapy.  13 (2022)  - p. 53-66 , 2022
Link: https://doi.org/10.2147/..
 
?
6

Role of 3'-Deoxy-3'-[18F] Fluorothymidine Positron Emission..:

Szyszko, Teresa A. ; Dunn, Joel T. ; Phillips, Melissa M....
JTO Clinical and Research Reports.  3 (2022)  9 - p. 100382 , 2022
Link: https://doi.org/10.1016/..
 
?
7

A Phase 1 study of ADI‐PEG20 (pegargiminase) combined with ..:

Chan, Pui Ying ; Phillips, Melissa M. ; Ellis, Stephen...
Pigment Cell & Melanoma Research.  35 (2022)  4 - p. 461-470 , 2022
Link: https://doi.org/10.1111/..
 
?
8

Phase 1, pharmacogenomic, dose‐expansion study of pegargimi..:

Szlosarek, Peter W. ; Wimalasingham, Akhila G. ; Phillips, Melissa M....
Cancer Medicine.  10 (2021)  19 - p. 6642-6652 , 2021
Link: https://doi.org/10.1002/..
 
?
9

Phase 1b study of pegylated arginine deiminase (ADI-PEG 20)..:

Chang, Kwang-Yu ; Chiang, Nai-Jung ; Wu, Shang-Yin...
OncoImmunology.  10 (2021)  1 - p. , 2021
Link: https://doi.org/10.1080/..
 
?
10

Cancer Burden Is Controlled by Mural Cell-β3-Integrin Regul..:

Wong, Ping-Pui ; Muñoz-Félix, José M. ; Hijazi, Maruan...
Cell.  181 (2020)  6 - p. 1346-1363.e21 , 2020
Link: https://doi.org/10.1016/..
 
?
11

Phase II Study of Arginine Deprivation Therapy With Pegargi..:

Hall, Peter E. ; Ready, Neal ; Johnston, Amanda...
Clinical Lung Cancer.  21 (2020)  6 - p. 527-533 , 2020
Link: https://doi.org/10.1016/..
 
?
12

Expansion Phase 1 Study of Pegargiminase Plus Pemetrexed an..:

Szlosarek, Peter W. ; Phillips, Melissa M. ; Pavlyk, Iuliia...
JTO Clinical and Research Reports.  1 (2020)  4 - p. 100093 , 2020
Link: https://doi.org/10.1016/..
 
?
13

A major responder to ipilimumab and nivolumab in metastatic..:

Chan, Pui Ying ; Hall, Peter ; Hay, Gordon..
Pigment Cell & Melanoma Research.  30 (2017)  6 - p. 558-562 , 2017
Link: https://doi.org/10.1111/..
 
?
14

Optimizing arginine deprivation for hard-to-treat cancers:

Khadeir, Ramsay ; Szyszko, Teresa ; Szlosarek, Peter W.
Oncotarget.  8 (2017)  57 - p. 96468-96469 , 2017
Link: https://doi.org/10.18632..
 
?
15

Clinical activity and safety of Pembrolizumab in Ipilimumab..:

Karydis, Ioannis ; Chan, Pui Ying ; Wheater, Matthew...
OncoImmunology.  5 (2016)  5 - p. e1143997 , 2016
Link: https://doi.org/10.1080/..
 
1-15